CN116439372A - High-water-solubility lutein powder and preparation method thereof - Google Patents
High-water-solubility lutein powder and preparation method thereof Download PDFInfo
- Publication number
- CN116439372A CN116439372A CN202210011979.7A CN202210011979A CN116439372A CN 116439372 A CN116439372 A CN 116439372A CN 202210011979 A CN202210011979 A CN 202210011979A CN 116439372 A CN116439372 A CN 116439372A
- Authority
- CN
- China
- Prior art keywords
- lutein
- solubility
- water
- powder
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 title claims abstract description 138
- 235000012680 lutein Nutrition 0.000 title claims abstract description 137
- 239000001656 lutein Substances 0.000 title claims abstract description 137
- 229960005375 lutein Drugs 0.000 title claims abstract description 137
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 title claims abstract description 137
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 title claims abstract description 137
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 title claims abstract description 132
- 239000000843 powder Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- -1 glucosyl stevioside Chemical compound 0.000 claims abstract description 30
- 229940013618 stevioside Drugs 0.000 claims abstract description 29
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 29
- 235000019202 steviosides Nutrition 0.000 claims abstract description 29
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract description 25
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 25
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 25
- 229960003943 hypromellose Drugs 0.000 claims abstract description 22
- 238000001694 spray drying Methods 0.000 claims abstract description 11
- 238000001556 precipitation Methods 0.000 claims abstract description 8
- 239000012296 anti-solvent Substances 0.000 claims abstract description 4
- 230000008878 coupling Effects 0.000 claims abstract description 4
- 238000010168 coupling process Methods 0.000 claims abstract description 4
- 238000005859 coupling reaction Methods 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 238000003760 magnetic stirring Methods 0.000 claims description 14
- 239000000725 suspension Substances 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000012456 homogeneous solution Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 8
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 7
- 229910052782 aluminium Inorganic materials 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 239000011888 foil Substances 0.000 claims description 7
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 235000006708 antioxidants Nutrition 0.000 claims description 3
- 238000009461 vacuum packaging Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 11
- 230000008569 process Effects 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 235000013402 health food Nutrition 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 238000003860 storage Methods 0.000 abstract description 2
- 238000004458 analytical method Methods 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- IMMBLRJLSYJQIZ-UNQGIHKMSA-N (2S)-7-[3,4-dihydroxy-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxy-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one Chemical compound COc1ccc(cc1O)[C@@H]1CC(=O)c2c(O)cc(OC3OC(COC4OC(C)C(O)C(O)C4O)C(OC4OC(CO)C(O)C(O)C4O)C(O)C3O)cc2O1 IMMBLRJLSYJQIZ-UNQGIHKMSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 125000003690 ionone group Chemical group 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 235000020674 meso-zeaxanthin Nutrition 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 108091005601 modified peptides Proteins 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 230000004112 neuroprotection Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 238000011197 physicochemical method Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 150000003735 xanthophylls Chemical class 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses high water-solubility lutein powder and a preparation method thereof, which are a process technology for modifying lutein from hydrophobicity to hydrophilicity, and belong to the technical field of processing of nutritional health foods. The lutein and the glucosyl stevioside and hypromellose interact to form a semi-interpenetrating network structure by coupling under specific conditions such as anti-solvent precipitation, dynamic ultrahigh-pressure micro-jet, spray drying and the like, so that the high-water-solubility lutein powder with amorphous form and improved stability is prepared. The apparent solubility of lutein of the product can be increased by more than 5000 times, and the storage stability of lutein is enhanced in a low-temperature light-resistant environment. The preparation method is simple, and has the characteristics of green process conditions, natural raw materials and auxiliary materials and the like.
Description
Technical Field
The invention belongs to the technical field of processing of nutritional health foods, and relates to high-water-solubility lutein powder and a preparation method thereof.
Background
Lutein is a dihydroxycarotenoid whose polyisoprene structure contains ionone ring, and is not only related to neuroprotection and anticancer effect, but also can effectively prevent eye diseases. Lutein, zeaxanthin and meso-zeaxanthin are the primary pigments residing in the macula of the eye for absorbing actinic blue light that may cause peroxidation of retinal lipids. This property is associated with protection against age-related macular degeneration. These unique physiological functions of lutein are increasingly gaining importance in the development of nutritional health foods. However, because lutein is extremely insoluble in water, the application of lutein in liquid preparations such as beverages, oral liquids and other nutritional and healthy products is greatly influenced.
In order to widen the application range of the lutein in the food and pharmaceutical industries, researchers enhance the water solubility of the lutein by combining a solubility promoting substance with a physicochemical method. In the prior patent, a preparation method of alpha-glucosyl hesperidin modified lutein liposome (application number: 201811581803.5) is disclosed, lutein and lipid materials are dissolved to obtain lutein lipid solution, lipid membranes are hydrated, dispersion liquid is obtained after ultrasonic treatment, the alpha-glucosyl hesperidin solution is dropwise added into the dispersion liquid, stirring is carried out at room temperature overnight, and the lutein liposome is obtained after extrusion through a polycarbonate membrane. The preparation process of water soluble lutein powder is disclosed, and includes mixing lutein crystal with low boiling point organic solvent with high solubility to lutein crystal and heating to dissolve to obtain oil phase; mixing the modified starch with water, heating, dissolving and cooling to obtain a water phase; adding the oil phase into the water phase, and emulsifying to obtain a mixed solution; homogenizing with high pressure homogenizer, removing organic solvent in the emulsion system, and removing water in the emulsion by spray drying or spray fluidized bed drying to obtain water-soluble lutein dry powder. Disclosed is a water-soluble lutein granule and its preparing process (application number: 201410791127. X), wherein the water-soluble lutein granule is obtained by passing mixed powder of lutein and water-soluble polymer auxiliary material through supercritical fluid recrystallization equipment. The water-soluble lutein is prepared by adopting a solvent-free decompression melting method, and has the dissolution rate of up to 98 percent, high stability and good dispersibility. Disclosed is a method for preparing water-soluble lutein by low-temperature melt extrusion and the product (application number: 201710295890.7), wherein the water-soluble lutein with high dissolution rate is obtained by mixing lutein with nonionic polymer surfactant and extruding the mixture under a certain condition by a hot melt extruder. Disclosed is a water-soluble lutein emulsion gel and its preparing process (application number: 202010981306.5), wherein corn peptide is dispersed under water-soluble condition for incubation, and modified peptide powder is obtained through vacuum freeze drying; dispersing corn peptide in distilled water, mixing with corn oil containing lutein, homogenizing under high pressure to form coarse emulsion; the lyophilized denatured peptide powder was added to the above crude emulsion and thoroughly mixed to completely hydrate lutein, and further gluconolactone was added and incubated at 25 ℃ to obtain lutein emulsion gel. The invention discloses a green preparation method (application number: 201711178383.1) of water-soluble lutein, which takes lutein as a raw material, wherein the prescription composition and the mass ratio of lutein to stevioside=1:2-1:10, and the water-soluble lutein with high stability and high solubility is obtained by adopting low-frequency ultrasound, high-pressure shearing and natural antioxidant use through non-covalent combination of lutein and stevioside molecules and modification of specific methods and conditions.
The problems of the technology are that 1) the emulsifier and the organic reagent with larger toxicity are used more, the environment pollution is caused, and the prepared water-soluble lutein has harmful reagent residues with different degrees; 2) The obtained water-soluble lutein has an unobvious dissolution promoting effect, and the solution can be subjected to a resolution phenomenon in the storage process; the temperature in the preparation process is higher, and the degradation loss of lutein is easy to cause; 3) Lutein in the obtained product is totally embedded in amphiphilic substances, and the lutein absorption and utilization are limited by the capacity of micelle to release lutein. Therefore, a new green preparation method or process technology is required to be sought, the use of toxic and harmful reagents is reduced while the water solubility is increased, and the water solubility stability and bioavailability of lutein are effectively improved.
Disclosure of Invention
Technical problem
The invention aims to provide water-soluble lutein powder with high water solubility and high stability and a preparation method thereof.
Technical proposal
A high water-solubility lutein powder and a preparation method thereof are characterized in that lutein, glucosyl stevioside and hypromellose molecules are interacted to form a semi-interpenetrating network structure by coupling specific conditions such as anti-solvent precipitation, dynamic ultrahigh-pressure micro-jet, spray drying and the like, so that the high water-solubility lutein powder with amorphous state and improved stability is prepared.
The preparation method of the water-soluble lutein powder comprises the following steps:
(1) Fully dissolving high-purity lutein in absolute ethyl alcohol, then slowly and uniformly adding the high-purity lutein into an aqueous solution containing glucosyl stevioside, hypromellose and natural water-soluble antioxidants under a magnetic stirring state, and stirring for 20-30 minutes at a magnetic stirring rotating speed of 400-600 rpm to obtain a suspension;
(2) Carrying out dynamic ultrahigh pressure micro-jet circulation treatment on the suspension obtained in the step (1) for 3 times at a treatment pressure of 100-150 MPa to obtain a micro-jet homogeneous solution;
(3) And (3) carrying out spray drying on the micro-jet homogeneous solution obtained in the step (2), controlling the air inlet temperature to be 180 ℃, the feeding temperature to be 50-60 ℃ and the feeding speed to be 5mL/min, so as to obtain water-soluble lutein powder, and packaging by adopting vacuum aluminum foil.
The volume ratio of the lutein absolute ethyl alcohol solution to the aqueous solution containing glucosyl stevioside and hypromellose is 1:100-1:200.
The mass ratio of lutein, glucosyl stevioside and hypromellose in the high water-solubility lutein powder is 1:40:0.5.
The water-soluble lutein powder has good water solubility, and the apparent solubility of lutein reaches more than 2800 mug/mL.
The technical effects are as follows:
1. the glucosyl stevioside is a safe food additive, is obtained by modifying natural stevioside by an enzyme method, and covers the bitter taste of a natural stevioside aglycone mother nucleus structure. Glycosylation is an important step in the structural modification of biologically active compounds, and the aggregated nanostructure of the glycosylated species plays an important role in enhancing the apparent solubility of hydrophobic biologically active species by forming a shell self-associated micelle-like structure having a hydrophobic backbone core and surrounded by sugar groups. Hypromellose is a polymer crystallization inhibitor, and can improve the solubility of active substances, maintain a high-level supersaturation state, and further inhibit the formation of crystallization and precipitation in a liquid environment. By utilizing the respective performance characteristics of the two substances and adopting specific methods and conditions such as an anti-solvent precipitation method, ultra-high pressure micro-jet and the like, a lutein compound system is constructed, so that the apparent solubility of lutein is increased by more than 5000 times, and the stability is good. In the invention, on one hand, the non-covalent combination of hydrogen bond, hydrophobic effect, van der Waals force and the like between glucosyl stevioside and lutein is utilized to form a water-soluble compound, and on the other hand, the hydroxypropyl methylcellulose is used to enable the compound to reach a supersaturated stable state, so that the formation of crystals is inhibited. In addition, the interaction between molecules in the solution is enhanced by utilizing an impinging stream technology through ultrahigh pressure microjet, so that the particle size of the lutein compound is reduced, and the uniform and stable lutein supersaturated solution is obtained.
2. Compared with the prior art, the preparation method mainly utilizes special interaction between compound molecules and coupling with physical and chemical means, uses natural and safe auxiliary materials, and has green and efficient preparation process. The lutein is in a supersaturated state by adopting operations such as ultra-high pressure shearing homogenization treatment, precipitation inhibitors and the like, so that substances such as lutein are prevented from being separated out in a solution, and the stability of water-soluble lutein is enhanced.
3. The existing researches show that the glucosyl stevioside is a natural sweetener, has a certain antioxidant activity, has the functions of reducing blood sugar, preventing decayed teeth, resisting diarrhea, promoting urination, relieving fatigue and the like, and has the auxiliary treatment effect on patients with diabetes, heart disease, hypertension, arteriosclerosis and the like; the glucosyl stevioside covers the original after-bitter taste on the basis of the stevioside, and the glucosyl stevioside is used for enabling the lutein compound system to form a supersaturated system in the water phase, so that the apparent solubility of lutein is promoted. However, since the supersaturated system is in a thermodynamically metastable state, the system is likely to be shifted to a direction in which free energy is reduced, such as precipitation or phase separation. The stability of the supersaturated solution is maintained by the addition of the precipitation inhibitor, hydroxypropyl cellulose. And hydroxypropyl cellulose is a cellulose derivative, an auxiliary material for oral and external preparations, and also often used for foods and cosmetics, and is considered to be a nontoxic, non-irritating substance. The addition of the hydroxypropyl methylcellulose can further improve the apparent solubility of lutein, form stable supersaturated solution and improve the absorption and utilization of lutein in intestinal tracts. Therefore, the water-soluble lutein compound system formed by combining glucosyl stevioside and hypromellose to load lutein plays an important role in improving the bioavailability of lutein.
Drawings
FIG. 1 is a graph showing apparent solubility of water-soluble xanthophylls.
FIG. 2 is an infrared spectrum of water-soluble lutein.
Detailed Description
The invention is further described in connection with the following description, but the scope of the invention as claimed is not limited to the examples described.
Example 1
Taking 50mg of lutein with the purity of 80% to be fully dissolved in 8mL of absolute ethyl alcohol solution, then slowly and uniformly adding the lutein into 800mL of water solution containing hypromellose and 0.05% of ascorbic acid under the magnetic stirring state, and stirring for 20 minutes at the magnetic stirring rotating speed of 400rpm to obtain suspension, wherein the mass ratio of lutein to hypromellose is 1:0.5-1:5. Carrying out dynamic ultrahigh pressure microjet treatment on the obtained suspension for 1 time, wherein the treatment pressure is 104MPa; the micro-jet homogeneous solution is subjected to spray drying treatment, the air inlet temperature is controlled to be 125 ℃, the feeding temperature is controlled to be 50 ℃, and the feeding speed is controlled to be 10mL/min. Obtaining water-soluble lutein powder, and packaging by adopting vacuum aluminum foil.
The obtained binary water-soluble lutein powder has apparent solubility of 0-350 mug/mL by high performance liquid chromatography analysis, wherein the optimal mass ratio of lutein to hypromellose is 1:0.5, and the apparent solubility of lutein is 320.75 mug/mL.
Example 2
50mg of lutein with the purity of 85% is fully dissolved in 8mL of absolute ethanol solution, and then slowly and uniformly added into 800mL of water solution containing glucosyl stevioside and 0.05% of ascorbic acid under the magnetic stirring state. The magnetic stirring speed is 500rpm, the stirring time is 20 minutes, and the suspension is obtained, and the mass ratio of lutein to glucosyl stevioside is 1:1-1:40. Carrying out dynamic ultrahigh pressure microjet circulation treatment on the obtained suspension for 2 times, wherein the treatment pressure is 110MPa; the micro-jet homogeneous solution is subjected to spray drying treatment, the air inlet temperature is controlled to be 130 ℃, the feeding temperature is controlled to be 45 ℃, and the feeding speed is controlled to be 8mL/min. Obtaining water-soluble lutein powder, and packaging by adopting vacuum aluminum foil.
The obtained binary water-soluble lutein powder has apparent solubility of 0-800 mug/mL by high performance liquid chromatography analysis, wherein the optimal mass ratio of lutein to glucosyl stevioside is 1:20, and the apparent solubility of lutein is 683.08 mug/mL.
Example 3
50mg of lutein with the purity of 85% is fully dissolved in 8mL of absolute ethanol solution, and then slowly and uniformly added into 1200mL of aqueous solution containing 0.5g of glucosyl stevioside, different mass of hypromellose and 0.01% of tea polyphenol under the magnetic stirring state. The magnetic stirring speed is 400rpm, the stirring time is 25 minutes, and the suspension is obtained, and the mass ratio of lutein to hypromellose is 1:0.5-1:2. Carrying out dynamic ultrahigh pressure microjet circulation treatment on the obtained suspension for 2 times, wherein the treatment pressure is 124MPa; the micro-jet homogeneous solution is subjected to spray drying treatment, the air inlet temperature is controlled to 140 ℃, the feeding temperature is controlled to 45 ℃, and the feeding speed is controlled to 6mL/min. Obtaining water-soluble lutein powder, and packaging by adopting vacuum aluminum foil.
The apparent solubility of the lutein obtained by high performance liquid chromatography analysis of the ternary water-soluble lutein powder reaches 500-1500 mug/mL, wherein the optimal mass ratio of the lutein to the glucosyl stevioside to the hypromellose is 1:10:0.5, and the apparent solubility of the lutein is 1245.40 mug/mL.
Example 4
50mg of lutein with purity of 90% is fully dissolved in 8mL of absolute ethanol solution, and then slowly and uniformly added into 1600mL of aqueous solution containing 1g of glucosyl stevioside, different mass of hypromellose and 0.01% of tea polyphenol under the magnetic stirring state. The magnetic stirring speed is 550rpm, the stirring time is 25 minutes, and the suspension is obtained, and the mass ratio of lutein to hypromellose is 1:0.5-1:5. Carrying out dynamic ultrahigh pressure micro-jet circulation treatment on the suspension for 2 times, wherein the treatment pressure is 138MPa; the micro-jet homogeneous solution is subjected to spray drying treatment, the air inlet temperature is controlled to be 165 ℃, the feeding temperature is controlled to be 40 ℃, and the feeding speed is controlled to be 6mL/min. Obtaining water-soluble lutein powder, and packaging by adopting vacuum aluminum foil.
The apparent solubility of the lutein obtained by high performance liquid chromatography analysis of the ternary water-soluble lutein powder reaches 1500-2000 mug/mL, wherein the optimal mass ratio of the lutein to the glucosyl stevioside to the hypromellose is 1:20:2, and the apparent solubility of the lutein is 2093.30 mug/mL.
Example 5
50mg of lutein with the purity of 95% is fully dissolved in 8mL of absolute ethanol solution, then slowly and uniformly added to the solution under the magnetic stirring state, and the solution contains 2g of glucosyl stevioside, different mass hydroxypropyl methylcellulose and 0.01% tea polyphenol, and the solution is respectively added into 1600mL of aqueous solution. The magnetic stirring speed is 600rpm, the stirring time is 30 minutes, a suspension is obtained, and the mass ratio of lutein to hypromellose is 1:0.5-1:5. Carrying out dynamic ultrahigh pressure micro-jet circulation treatment on the suspension for 3 times, wherein the treatment pressure is 138MPa; the micro-jet homogeneous solution is subjected to spray drying treatment, the air inlet temperature is controlled to be 165 ℃, the feeding temperature is controlled to be 35 ℃, and the feeding speed is controlled to be 6mL/min. Obtaining water-soluble lutein powder, and packaging by adopting vacuum aluminum foil.
The apparent solubility of lutein obtained by high-water-solubility lutein powder is 1500-3000 mug/mL by high performance liquid chromatography analysis, wherein the optimal mass ratio of lutein to glucosyl stevioside to hypromellose is 1:40:0.5, and the apparent solubility of lutein is 2805.47 mug/mL.
Example 6
Determination of lutein content in water-soluble lutein powder:
high performance liquid chromatography (C) was performed with 5mL of methanol reconstituted water-soluble lutein powder 30 -HPLC) analysis.
C 30 HPLC-DAD analysis conditions: chromatographic column: YMC-C 30 Chromatographic column (4.6 mm. Times.250 mm,5 μm); mobile phase: a is water-MTBE-methanol (5:25:75, V/V/V), B is water-MTBE-methanol (5:85:10, V/V/V); elution gradient setup: 0-4.5 min,95% -80% A;4.5 to 12.5min,80 percent to 50 percent of A; 12.5-15 min,50% -95% A.
Determination of apparent solubility of lutein in water-soluble lutein powder:
drawing a lutein standard curve: 40mg of lutein is taken out into a clean 100mL volumetric flask, dissolved with absolute ethanol and fixed in volume to obtain a lutein stock solution of 400 mug/mL. Respectively precisely weighing standard stock solutions of 0.4, 0.8, 1.2, 1.6, 2.0 and 2.4mL in a volumetric flask of 10mL, diluting to scale with absolute ethanol, shaking uniformly to obtain solutions with mass concentrations of 16, 32, 48, 64, 80 and 96 mug/mL respectively, passing through a 0.45 mu m filter membrane, performing sample injection measurement, and drawing a lutein standard curve by taking the lutein serial standard solution mass concentration as an abscissa and the corresponding absorption peak area as an ordinate to obtain a regression equation: y=0.0093X-0.0082, r 2 =0.9996。
The apparent solubility of lutein in the water-soluble lutein powder is calculated as follows:
wherein: lutein content in C-powder, mg/g; y-absorption peak area; l-volume of redissolved solvent, mL; m-sample mass, g.
Claims (5)
1. A high water-solubility lutein powder and a preparation method thereof are characterized in that lutein, glucosyl stevioside and hypromellose molecules are interacted to form a semi-interpenetrating network structure by coupling specific conditions such as anti-solvent precipitation, dynamic ultrahigh-pressure micro-jet, spray drying and the like, so that the high water-solubility lutein powder with amorphous state and improved stability is prepared.
2. The lutein powder with high water solubility and the preparation method thereof are characterized by comprising the following steps:
(1) Fully dissolving high-purity lutein in absolute ethyl alcohol, then slowly and uniformly adding the high-purity lutein into an aqueous solution containing glucosyl stevioside, hypromellose and natural water-soluble antioxidants under a magnetic stirring state, and stirring for 20-30 minutes at a magnetic stirring rotating speed of 400-600 rpm to obtain a suspension;
(2) Carrying out dynamic ultrahigh pressure micro-jet circulation treatment on the suspension obtained in the step (1) for 3 times at a treatment pressure of 100-150 MPa to obtain a micro-jet homogeneous solution;
(3) And (3) carrying out spray drying on the micro-jet homogeneous solution obtained in the step (2), controlling the air inlet temperature to be 180 ℃, the feeding temperature to be 50-60 ℃ and the feeding speed to be 5mL/min, so as to obtain water-soluble lutein powder, and vacuum packaging by adopting aluminum foil.
3. The high water-solubility lutein powder and the preparation method thereof according to claim 2, wherein the volume ratio of the lutein absolute ethyl alcohol solution to the aqueous solution containing glucosyl stevioside and hypromellose in the step (1) is 1:100-1:200.
4. The high water-soluble lutein powder and the preparation method thereof according to claim 1 or 2, wherein the mass ratio of lutein, glucosyl stevioside and hypromellose in the high water-soluble lutein powder is 1:40:0.5.
5. The high water-solubility lutein powder and the preparation method thereof according to claim 1 or 2, wherein the high water-solubility lutein powder has good water solubility, and the apparent solubility of lutein reaches more than 2800 mug/mL.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210011979.7A CN116439372A (en) | 2022-01-06 | 2022-01-06 | High-water-solubility lutein powder and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210011979.7A CN116439372A (en) | 2022-01-06 | 2022-01-06 | High-water-solubility lutein powder and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116439372A true CN116439372A (en) | 2023-07-18 |
Family
ID=87118814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210011979.7A Pending CN116439372A (en) | 2022-01-06 | 2022-01-06 | High-water-solubility lutein powder and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116439372A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117964534A (en) * | 2024-03-28 | 2024-05-03 | 中国农业大学 | Amorphous lutein with improved solubility and preparation method thereof |
-
2022
- 2022-01-06 CN CN202210011979.7A patent/CN116439372A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117964534A (en) * | 2024-03-28 | 2024-05-03 | 中国农业大学 | Amorphous lutein with improved solubility and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2117353B1 (en) | Process for the manufacture of a powder containing carotenoids | |
Kaur et al. | A critical appraisal of solubility enhancement techniques of polyphenols | |
EP2594140B1 (en) | Nanoparticles for encapsulation of compounds, the production and uses thereof | |
JP2019059740A (en) | HIGHLY BRANCHED α-D-GLUCANS | |
WO2013185780A1 (en) | Enhancing the stability and purity and increasing the bioavailability of human milk oligosaccharides or precursors or blends thereof | |
US8613946B2 (en) | Carotenoids of enhanced bioavailability | |
EP2085097A1 (en) | Highly water-dispersible powder and method of producing the same | |
TWI445536B (en) | Soya sapogenol composition | |
Wang et al. | Characterizations and microsphere formulation of polysaccharide from the marine clam (Mactra veneriformis) | |
US20030232892A1 (en) | Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations | |
CN116439372A (en) | High-water-solubility lutein powder and preparation method thereof | |
CN110693027A (en) | Water-dispersible cannabidiol product and preparation method thereof | |
KR20200132584A (en) | Stabilized astaxanthin nanoparticles and its manufacturing method | |
WO2011050735A1 (en) | Paclitaxel/steroidal complex | |
CN114641317A (en) | 7, 8-dihydroxyflavone composite nano biomaterial with high bioavailability as well as preparation method and application thereof | |
TWI718235B (en) | A PARTICULATE COMPOSITION COMPRISING CRYSTALLINE α,α-TREHALOSE DIHYDRATE, ITS PRODUCTION AND USES | |
Uchiyama et al. | Single-stranded β-1, 3–1, 6-glucan as a carrier for improved dissolution and membrane permeation of poorly water-soluble compounds | |
CN107897647B (en) | Green preparation method of water-soluble lutein | |
JP6312801B2 (en) | Glycogen-based water solubility improver | |
JP2010105972A (en) | Water-soluble carotenoid composition | |
CN113317508A (en) | Water-soluble phytosterol nanoparticles and preparation method thereof | |
CN104095816A (en) | Lutein ester nano particle and preparation method thereof | |
Xie et al. | High resveratrol-loaded microcapsules with trehalose and OSA starch as the wall materials: Fabrication, characterization, and evaluation | |
EP3488709B1 (en) | Food product containing calcium salt granules and dietary fiber | |
JPH03151326A (en) | Method for improvement of biological usefulness of pharmaceutically effective substance having peptide bond |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |